DISCOUNT OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 14:48:12 2024-05-10 EDT | ||
| 1.78 EUR | -5.82% |
|
| Current month | +36.92% | ||
| 1 month | +20.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 1.78 | -5.82% | 0 |
| 24-05-09 | 1.89 | +11.83% | 0 |
| 24-05-08 | 1.69 | +6.96% | 0 |
| 24-05-07 | 1.58 | -27.85% | 0 |
| 24-05-06 | 2.19 | -12.40% | 0 |
Delayed Quote Börse Stuttgart
Last update May 10, 2024 at 02:48 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME6QK1 |
| ISIN | DE000ME6QK12 |
| Date issued | 2024-01-10 |
| Strike | 380 $ |
| Maturity | 2024-09-20 (132 Days) |
| Parity | 1 : 1 |
| Emission price | 2.31 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.73 € |
|---|---|
| Lowest since issue | 1.01 € |
| Spread | 0.09 € |
| Spread % | 4.86% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat